[High-flow nasal oxygen in acute hypoxemic respiratory failure]
- PMID: 35918276
- DOI: 10.1016/j.rmr.2022.06.001
[High-flow nasal oxygen in acute hypoxemic respiratory failure]
Abstract
Although standard oxygen is the first-line therapy in patients with acute hypoxemic respiratory failure, high-flow nasal oxygen has gained major popularity in ICUs due to its simplicity of application, good comfort for patients, and efficiency in improving oxygenation. Physiological effects of high-flow oxygen therapy can limit the physiological consequences of acute hypoxemic respiratory failure and may mitigate the deleterious effects of high and prolonged inspiratory efforts generated by patients. Although clinical studies have reported a decreased risk of intubation with high-flow oxygen therapy as compared with conventional oxygen therapy, its benefits with regard to survival are uncertain. However, a more precise definition of acute hypoxemic respiratory failure including a classification of severity levels based on oxygenation levels is needed, the objective being to better compare the efficiency of different non-invasive oxygenation supports (conventional oxygen therapy, high-flow oxygen and non-invasive ventilation). Moreover, other clinical trials are needed to confirm the place and the benefit of these oxygenation supports, particularly high-flow nasal oxygen therapy, in acute hypoxemic respiratory failure, especially in the severe forms.
Keywords: Acute respiratory failure; Haut débit nasal; Hypoxemia; Hypoxémie; Insuffisance respiratoire aiguë; Nasal high flow; Oxygen; Oxygène.
Copyright © 2022 SPLF. Published by Elsevier Masson SAS. All rights reserved.
Similar articles
-
High-Flow Nasal Cannula Oxygenation in Immunocompromised Patients With Acute Hypoxemic Respiratory Failure: A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study.Crit Care Med. 2017 Mar;45(3):e274-e280. doi: 10.1097/CCM.0000000000002085. Crit Care Med. 2017. PMID: 27655324 Clinical Trial.
-
High-flow nasal cannula oxygen therapy in acute hypoxemic respiratory failure and COVID-19-related respiratory failure.J Intensive Med. 2023 Jan 31;3(1):20-26. doi: 10.1016/j.jointm.2022.07.005. Epub 2022 Sep 29. J Intensive Med. 2023. PMID: 36756183 Free PMC article. Review.
-
[High-flow nasal oxygen therapy and hypercapnic acute respiratory failure].Rev Mal Respir. 2024 Sep;41(7):498-507. doi: 10.1016/j.rmr.2024.06.002. Epub 2024 Jun 25. Rev Mal Respir. 2024. PMID: 38926023 Review. French.
-
Noninvasive Oxygenation in Patients with Acute Respiratory Failure: Current Perspectives.Int J Gen Med. 2022 Apr 7;15:3121-3132. doi: 10.2147/IJGM.S294906. eCollection 2022. Int J Gen Med. 2022. PMID: 35418775 Free PMC article. Review.
-
Predictors of Intubation in Patients With Acute Hypoxemic Respiratory Failure Treated With a Noninvasive Oxygenation Strategy.Crit Care Med. 2018 Feb;46(2):208-215. doi: 10.1097/CCM.0000000000002818. Crit Care Med. 2018. PMID: 29099420 Clinical Trial.
Cited by
-
HACOR score to predict NIV failure in patients with COVID-related hypoxemic respiratory failure managed in the ordinary ward and in the critical care setting.Intern Emerg Med. 2024 Nov;19(8):2319-2329. doi: 10.1007/s11739-024-03628-1. Epub 2024 May 13. Intern Emerg Med. 2024. PMID: 38739206
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical